249 related articles for article (PubMed ID: 20701792)
1. Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.
Tai CJ; Hsu CH; Shen SC; Lee WR; Jiang MC
J Exp Clin Cancer Res; 2010 Aug; 29(1):110. PubMed ID: 20701792
[TBL] [Abstract][Full Text] [Related]
2. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.
Jiang MC
Tumour Biol; 2016 Oct; 37(10):13077-13090. PubMed ID: 27596143
[TBL] [Abstract][Full Text] [Related]
3. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.
Liao CF; Luo SF; Li LT; Lin CY; Chen YC; Jiang MC
J Exp Clin Cancer Res; 2008 Jul; 27(1):15. PubMed ID: 18597698
[TBL] [Abstract][Full Text] [Related]
4. CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs.
Liao CF; Luo SF; Shen TY; Lin CH; Chien JT; Du SY; Jiang MC
BMB Rep; 2008 Mar; 41(3):210-6. PubMed ID: 18377724
[TBL] [Abstract][Full Text] [Related]
5. Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer.
Stella Tsai CS; Chen HC; Tung JN; Tsou SS; Tsao TY; Liao CF; Chen YC; Yeh CY; Yeh KT; Jiang MC
Am J Pathol; 2010 Apr; 176(4):1619-28. PubMed ID: 20150437
[TBL] [Abstract][Full Text] [Related]
6. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF.
Li Y; Yuan S; Liu J; Wang Y; Zhang Y; Chen X; Si W
J Cell Physiol; 2020 Mar; 235(3):2071-2079. PubMed ID: 31347172
[TBL] [Abstract][Full Text] [Related]
7. Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer.
Tung MC; Tsai CS; Tung JN; Tsao TY; Chen HC; Yeh KT; Liao CF; Jiang MC
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1570-7. PubMed ID: 19383891
[TBL] [Abstract][Full Text] [Related]
8. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.
Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF
FASEB J; 2012 Jun; 26(6):2446-56. PubMed ID: 22389439
[TBL] [Abstract][Full Text] [Related]
9. LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer.
Ma S; Yang D; Liu Y; Wang Y; Lin T; Li Y; Yang S; Zhang W; Zhang R
Aging (Albany NY); 2018 Aug; 10(8):2062-2078. PubMed ID: 30144787
[TBL] [Abstract][Full Text] [Related]
10. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.
Liao CF; Lin SH; Chen HC; Tai CJ; Chang CC; Li LT; Yeh CM; Yeh KT; Chen YC; Hsu TH; Shen SC; Lee WR; Chiou JF; Luo SF; Jiang MC
Mol Med; 2012 Dec; 18(1):1269-80. PubMed ID: 22952058
[TBL] [Abstract][Full Text] [Related]
11. Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.
Tai CJ; Su TC; Jiang MC; Chen HC; Shen SC; Lee WR; Liao CF; Chen YC; Lin SH; Li LT; Shen KH; Yeh CM; Yeh KT; Lee CH; Shih HY; Chang CC
J Transl Med; 2013 Jan; 11():29. PubMed ID: 23369209
[TBL] [Abstract][Full Text] [Related]
12. PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer.
Salvi A; Young AN; Huntsman AC; Pergande MR; Korkmaz MA; Rathnayake RA; Mize BK; Kinghorn AD; Zhang X; Ratia K; Schirle M; Thomas JR; Brittain SM; Shelton C; Aldrich LN; Cologna SM; Fuchs JR; Burdette JE
Cell Death Dis; 2022 Jan; 13(1):45. PubMed ID: 35013112
[TBL] [Abstract][Full Text] [Related]
13. Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus.
Jiang K; Neill K; Cowden D; Klapman J; Eschrich S; Pimiento J; Malafa MP; Coppola D
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):552-556. PubMed ID: 27941559
[TBL] [Abstract][Full Text] [Related]
14. Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells.
Jiang MC; Luo SF; Li LT; Lin CC; Du SY; Lin CY; Hsu YW; Liao CF
J Exp Clin Cancer Res; 2007 Mar; 26(1):91-9. PubMed ID: 17550137
[TBL] [Abstract][Full Text] [Related]
15. CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.
Cheng DD; Lin HC; Li SJ; Yao M; Yang QC; Fan CY
Sci Rep; 2017 Apr; 7():46238. PubMed ID: 28387323
[TBL] [Abstract][Full Text] [Related]
16. Does CSE1L Overexpression Affect Distant Metastasis Development in Breast Cancer?
Yuksel UM; Turker I; Dilek G; Dogan L; Gulcelik MA; Oksuzoglu B
Oncol Res Treat; 2015; 38(9):431-4. PubMed ID: 26278417
[TBL] [Abstract][Full Text] [Related]
17. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
[TBL] [Abstract][Full Text] [Related]
18. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells.
Tai CJ; Shen SC; Lee WR; Liao CF; Deng WP; Chiou HY; Hsieh CI; Tung JN; Chen CS; Chiou JF; Li LT; Lin CY; Hsu CH; Jiang MC
Exp Cell Res; 2010 Oct; 316(17):2969-81. PubMed ID: 20688056
[TBL] [Abstract][Full Text] [Related]
19. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
[TBL] [Abstract][Full Text] [Related]
20. Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells.
Zhu JH; Hong DF; Song YM; Sun LF; Wang ZF; Wang JW
Asian Pac J Cancer Prev; 2013; 14(2):1017-21. PubMed ID: 23621178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
